Search

Michal Zalzman

from Towson, MD
Age ~51
Get Report
Related to:
Amihai M Zalzman, 26Amihai M Zalzman, 42Amihai Zalzman, 51
Connected to:
Cin Zam, 51Jennifer J Zam, 54Sean L Zam, 46Cromwell N Zama, 56Mohammad A Zama, 45Christine M Zamagias, 61Andrew D Zamagni, 57Benjamin S Zamago, 64Linda E Zamaitis, 65Mariusz Zamajtys, 49

Michal Zalzman Phones & Addresses

  • 1713 Roland Ave, Towson, MD 21204
  • 2933 Katewood Ct, Baltimore, MD 21209
  • 6813 Pimlico Rd, Baltimore, MD 21209
  • Pikesville, MD
  • Philadelphia, PA
  • Milford, PA
  • 6813 Pimlico Dr, Baltimore, MD 21209

Work

Company: National institutes of health Feb 2007 to Feb 2012 Position: Postdoctoral-fellow

Skills

Molecular Biology • Cell • Stem Cells • Biochemistry • Genetics • In Vitro • Cancer Research • Telomere Research • Fluorescence • Genomics • Cancer • Tissue Engineering • Cell Biology • Laboratory • Animal Models • Tissue Culture • Rna Isolation • Confocal Microscopy • Lifesciences • Fluorescence Microscopy • Qpcr • Immunohistochemistry • Rt Pcr • Molecular Genetics • Dna • Microscopy • Immunofluorescence • Molecular Cloning • Cell Culture • Transfection • In Vivo • Immunoprecipitation • Pcr • Assay Development • Cell Signaling • Protein Expression • Western Blotting • Developmental Biology • Protein Chemistry • Bioinformatics • Aging Research • Flow Cytometry • Protein Purification • Elisa • Proteomics • Recombinant Dna Technology • Dna Sequencing • Microarray Analysis • Life Sciences

Industries

Higher Education

Resumes

Resumes

Michal Zalzman Photo 1

Assistant Professor

View page
Location:
Baltimore, MD
Industry:
Higher Education
Work:
National Institutes of Health Feb 2007 - Feb 2012
Postdoctoral-Fellow
University of Maryland Feb 2007 - Feb 2012
Assistant Professor
Tel Aviv Univesity 2005 - 2007
Postdoc
Tel Aviv University 2001 - 2005
Ph.d
Tel Aviv University 1997 - 1999
M.sc Human Molecular Genetics
Skills:
Molecular Biology
Cell
Stem Cells
Biochemistry
Genetics
In Vitro
Cancer Research
Telomere Research
Fluorescence
Genomics
Cancer
Tissue Engineering
Cell Biology
Laboratory
Animal Models
Tissue Culture
Rna Isolation
Confocal Microscopy
Lifesciences
Fluorescence Microscopy
Qpcr
Immunohistochemistry
Rt Pcr
Molecular Genetics
Dna
Microscopy
Immunofluorescence
Molecular Cloning
Cell Culture
Transfection
In Vivo
Immunoprecipitation
Pcr
Assay Development
Cell Signaling
Protein Expression
Western Blotting
Developmental Biology
Protein Chemistry
Bioinformatics
Aging Research
Flow Cytometry
Protein Purification
Elisa
Proteomics
Recombinant Dna Technology
Dna Sequencing
Microarray Analysis
Life Sciences

Publications

Us Patents

Methods For Enhancing Genome Stability And Telomere Elongation In Embryonic Stem Cells

View page
US Patent:
20120156305, Jun 21, 2012
Filed:
Sep 2, 2010
Appl. No.:
13/393456
Inventors:
Minoru S.H. Ko - Cockeysville MD, US
Michal Zalzman - Baltimore MD, US
Lioudmila V. Sharova - Pasadena MD, US
International Classification:
A61K 38/02
C12N 5/0735
C12N 5/071
A61K 35/12
A61K 9/14
A61P 35/00
A61P 37/00
A61P 25/00
C12N 15/85
A61K 31/7088
B82Y 5/00
US Classification:
424499, 435455, 435375, 435366, 435354, 424 937, 514 193, 514 44 R, 435377, 977773, 977906
Abstract:
The disclosure provides methods for increasing genome stability of an embryonic stem (ES) cell or induced pluripotent stem (iPS) cell, increasing telomere length in an ES or iPS cell, or both, for example by contacting an ES or iPS cell with an agent that increases expression of Zscan4 in the cell. Methods for increasing the genome stability in a population of ES or iPS cells, increasing telomere length in a population of ES or iPS cells, or both, are provided, for example by selecting Zscan4 ES or iPS cells from the population of ES or iPS cells (which can include both Zscan4 and Zscan4ES or iPS cells). Therapeutic methods of using ES or iPS cells expressing Zscan4 are also provided. Further provided are methods of treating cancer by administering a Zscan4 polynucleotide or Zscan4 polypeptide. Also provided are methods of inducing differentiation of isolated ES or iPS cells into germ cells.

Methods For Enhancing Genome Stability And Telomere Elongation In Embryonic Stem Cells

View page
US Patent:
20140234969, Aug 21, 2014
Filed:
Apr 23, 2014
Appl. No.:
14/259600
Inventors:
- Bethesda MD, US
Michal Zalzman - Baltimore MD, US
Lioudmila V. Sharova - Pasadena MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Serv - Bethesda MD
International Classification:
C12N 15/85
C12N 15/86
US Classification:
435455
Abstract:
The disclosure provides methods for increasing genome stability of an embryonic stem (ES) cell or induced pluripotent stem (iPS) cell, increasing telomere length in an ES or iPS cell, or both, for example by contacting an ES or iPS cell with an agent that increases expression of Zscan4 in the cell. Methods for increasing genome stability or increasing telomere length in a population of ES or iPS cells are provided, for example by selecting Zscan4 ES or iPS cells from the population of ES or iPS cells (which can include both Zscan4 and Zscan4 ES or iPS cells). Therapeutic methods of using ES or iPS cells expressing Zscan4 are also provided. Further provided are methods of treating cancer by administering a Zscan4 polynucleotide or Zscan4 polypeptide. Also provided are methods of inducing differentiation of isolated ES or iPS cells into germ cells.
Control profile
Michal Zalzman from Towson, MD, age ~51 Get Report